# FDA Approves Novartis' Cosentyx To Treat Moderate To Severe Hidradenitis Suppurativa In Adults
**FDA Update**

**2023-11-01 01:33**

**https://www.ainvest.com/news/fda-approves-novartis-cosentyx-to-treat-moderate-to-severe-hidradenitis-suppurativa-in-adults-2310100000ef32ca306614fb/**

FDA Approves Novartis' Cosentyx To Treat Moderate To Severe Hidradenitis Suppurativa In Adults